Sleep Disorders Trial, Recruiting (NCT06002022)

Sleep Disorders Trial, Recruiting NCT06002022 Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06002022 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be willing and able to give written consent to take part before joining the trial, following local rules and regulations.
You have been diagnosed with stage I, II, or III breast cancer (confirmed by a tissue sample/biopsy) and are currently receiving hormone-based treatment (with or without having had chemotherapy before), and this treatment started no more than 12 months before joining the trial.
You are between 18 and 75 years of age.
You are expected to live for longer than 3 months after starting your treatment.
You are able to understand what the trial involves, take part in any required tests, and are willing to sign a consent form.
You do not have any psychological, family, social, or location-related difficulties that might make it hard to follow the trial's schedule and requirements.

Who may not be able to join:

You are not willing to sign a consent form agreeing to take part in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06002022

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

More information: https://clinicaltrials.gov/study/NCT06002022

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be willing and able to give written consent to take part before joining the trial, following local rules and regulations.
You have been diagnosed with stage I, II, or III breast cancer (confirmed by a tissue sample/biopsy) and are currently receiving hormone-based treatment (with or without having had chemotherapy before), and this treatment started no more than 12 months before joining the trial.
You are between 18 and 75 years of age.
You are expected to live for longer than 3 months after starting your treatment.
You are able to understand what the trial involves, take part in any required tests, and are willing to sign a consent form.
You do not have any psychological, family, social, or location-related difficulties that might make it hard to follow the trial's schedule and requirements.

Who may not be able to join:

You are not willing to sign a consent form agreeing to take part in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fundación para la Investigación del Hospital Clínico de Valencia

Registry

ClinicalTrials.gov

Start date

1 January 2024

Est. completion

28 July 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Resting quality; Stress level; Stress level related to illness; Pain level of the last 24 hours; Tiredness level of the last 24 hours

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov